Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 50.74%
March 31, 2026 49.01%
December 31, 2025 50.59%
September 30, 2025 53.70%
June 30, 2025 51.51%
March 31, 2025 51.61%
December 31, 2024 54.28%
September 30, 2024 54.59%
June 30, 2024 53.63%
March 31, 2024 52.39%
December 31, 2023 53.38%
September 30, 2023 51.65%
June 30, 2023 52.87%
March 31, 2023 54.78%
December 31, 2022 53.79%
September 30, 2022 51.46%
June 30, 2022 49.94%
March 31, 2022 50.73%
December 31, 2021 52.75%
September 30, 2021 53.62%
June 30, 2021 52.78%
March 31, 2021 49.02%
December 31, 2020 51.80%
September 30, 2020 51.23%
June 30, 2020 50.61%
Date Value
March 31, 2020 50.23%
December 31, 2019 53.44%
September 30, 2019 54.62%
June 30, 2019 53.79%
March 31, 2019 53.80%
December 31, 2018 54.41%
September 30, 2018 55.38%
June 30, 2018 57.06%
March 31, 2018 55.14%
December 31, 2017 56.92%
September 30, 2017 57.13%
June 30, 2017 56.50%
March 31, 2017 53.87%
December 31, 2016 55.89%
September 30, 2016 59.52%
June 30, 2016 58.18%
March 31, 2016 58.42%
December 31, 2015 60.92%
September 30, 2015 60.29%
June 30, 2015 58.97%
March 31, 2015 53.68%
December 31, 2014 56.70%
September 30, 2014 58.84%
June 30, 2014 59.60%
March 31, 2014 60.38%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 64.07%
Neogen Corp. 47.35%
QuidelOrtho Corp. 35.75%
Trinity Biotech Plc 0.00%
Aspira Women's Health, Inc. 55.28%